BofA Trims Constellation's Price Target, Sees Similar Investments From Beverage Companies On The Horizon

Constellation Brands, Inc. Class A STZ announced Wednesday an agreement to augment its stake in Canopy Growth Corp CGC from 9.9 percent to 38 percent.

The Analyst

Reviewing the transaction, Bank of America Merrill Lynch analyst Bryan Spillane reiterated his Buy rating on Constellation Brands, but reduced his price target from $250 to $230.

The Thesis

The expansion of Constellation's strategic relationship with Canopy Growth would increase its exposure to the cannabis market, while also providing funds for the latter, Spillane said in a Aug. 15 note.

The analyst noted Constellation Brands will receive additional warrants exercisable over the next three years, which when exercised would bring the company's ownership in Canopy Growth to 55 percent.

The increased investment, according to Spillane, means Constellation Brands can not only co-develop beverages but also participate in the development of medical/recreation cannabis on a global scale.

For Canopy Growth, the deal provides the much-needed finance to fund its expansion globally and consolidation in the Canadian market, BofA said.

"In our view, recreational expansion with cannabis based ingredients is likely to draw similar investment from other food/beverage cos," the firm said. Citing addition of interest on $4 billion of debt, the firm lowered its 2019-21 EPS estimates for Constellation Brands.

The Price Action

Constellation's stock, which shed 6 percent Wednesday, was down another 3 percent Thursday around $202.06 per share.

Related Links:

As Millennials Pivot From Booze To Buds, The Beer Industry Strikes Cannabis Partnerships

Citron Calls Tilray 'Next In Line' In Surging Cannabis Sector, Sets $45 Price Target

date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorCannabisShort SellersPrice TargetReiterationTop StoriesMarketsAnalyst RatingsBank of America Merrill LynchBryan SpillaneCitron Research
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...